195 related articles for article (PubMed ID: 20852645)
1. The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site.
Li Q; Qi J; Zhang W; Vavricka CJ; Shi Y; Wei J; Feng E; Shen J; Chen J; Liu D; He J; Yan J; Liu H; Jiang H; Teng M; Li X; Gao GF
Nat Struct Mol Biol; 2010 Oct; 17(10):1266-8. PubMed ID: 20852645
[TBL] [Abstract][Full Text] [Related]
2. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of 150-cavity formation in influenza neuraminidase.
Amaro RE; Swift RV; Votapka L; Li WW; Walker RC; Bush RM
Nat Commun; 2011 Jul; 2():388. PubMed ID: 21750542
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of the 1918 influenza virus H1N1 neuraminidase.
Xu X; Zhu X; Dwek RA; Stevens J; Wilson IA
J Virol; 2008 Nov; 82(21):10493-501. PubMed ID: 18715929
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel N-acetylneuraminic acid derivatives as substrates for rapid detection of influenza virus neuraminidase.
Yang W; Liu X; Peng X; Li P; Wang T; Tai G; James Li X; Zhou Y
Carbohydr Res; 2012 Oct; 359():92-6. PubMed ID: 22925770
[TBL] [Abstract][Full Text] [Related]
6. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites.
Maurer-Stroh S; Ma J; Lee RT; Sirota FL; Eisenhaber F
Biol Direct; 2009 May; 4():18; discussion 18. PubMed ID: 19457254
[TBL] [Abstract][Full Text] [Related]
7. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.
Varghese JN; Colman PM; van Donkelaar A; Blick TJ; Sahasrabudhe A; McKimm-Breschkin JL
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11808-12. PubMed ID: 9342319
[TBL] [Abstract][Full Text] [Related]
8. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
[TBL] [Abstract][Full Text] [Related]
9. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution.
Rameix-Welti MA; Munier S; Le Gal S; Cuvelier F; Agou F; Enouf V; Naffakh N; van der Werf S
Antivir Ther; 2011; 16(4):597-603. PubMed ID: 21685548
[TBL] [Abstract][Full Text] [Related]
11. Structure-aided drug development of potential neuraminidase inhibitors against pandemic H1N1 exploring alternate binding mechanism.
Malbari KD; Chintakrindi AS; Ganji LR; Gohil DJ; Kothari ST; Joshi MV; Kanyalkar MA
Mol Divers; 2019 Nov; 23(4):927-951. PubMed ID: 30710224
[TBL] [Abstract][Full Text] [Related]
12. Atypical group 1 neuraminidase pH1N1-N1 bound to a group 1 inhibitor.
Wu Y; Vavricka CJ; Wu Y; Li Q; Rudrawar S; Thomson RJ; von Itzstein M; Gao GF; Qi J
Protein Cell; 2015 Oct; 6(10):771-3. PubMed ID: 26334400
[No Abstract] [Full Text] [Related]
13. An Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic Activity.
Zanin M; Duan S; Wong SS; Kumar G; Baviskar P; Collin E; Russell C; Barman S; Hause B; Webby R
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847354
[TBL] [Abstract][Full Text] [Related]
14. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
15. Rapid differentiation of seasonal and pandemic H1N1 influenza through proteotyping of viral neuraminidase with mass spectrometry.
Schwahn AB; Wong JW; Downard KM
Anal Chem; 2010 Jun; 82(11):4584-90. PubMed ID: 20443622
[TBL] [Abstract][Full Text] [Related]
16. Influenza A virus N5 neuraminidase has an extended 150-cavity.
Wang M; Qi J; Liu Y; Vavricka CJ; Wu Y; Li Q; Gao GF
J Virol; 2011 Aug; 85(16):8431-5. PubMed ID: 21653672
[TBL] [Abstract][Full Text] [Related]
17. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
18. Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding.
Wu Y; Qin G; Gao F; Liu Y; Vavricka CJ; Qi J; Jiang H; Yu K; Gao GF
Sci Rep; 2013; 3():1551. PubMed ID: 23531861
[TBL] [Abstract][Full Text] [Related]
19. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
Singh A; Soliman ME
Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
[TBL] [Abstract][Full Text] [Related]
20. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
Kar P; Knecht V
J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
